Concerning B-cells EBV-related lymphomas, a study was conducted on IBD patients exposed to anti-TNFα agents, assessing the presence of EBV by quantifying EBV genomes in peripheral blood. This evidence concerns the gene TNF and inflammatory bowel disease.